The authors wish to make the following corrections to this paper \[[@B1-jcm-08-00546]\].

The authors have made a critical typing error and a counting error in [Table 2](#jcm-08-00546-t002){ref-type="table"} as the parameters of "Community-acquired infection" and "Healthcare-associated infection" were mistakenly switched with each other.

Accordingly, [Table 2](#jcm-08-00546-t002){ref-type="table"}, which is shown as follows: jcm-08-00546-t002_Table 2Table 2Demographic characteristics, clinical information, and outcome of patients with *E. meningoseptica* and *E. anophelis* infections.CharacteristicsAll (*n* = 92)Number of Episodes (%)OR (95% CI)*p-*Value*E. meningoseptica*\
(*n* = 20)*E. anophelis*\
(*n* = 72)SexMale64 (69.6)15 (75)49 (68.1)1.41 (0.46--4.35)0.55Female28 (30.4)5 (25)23 (31.9)0.71 (0.23--2.19)0.55AgeRange (year)3--8918--803--89Median (year)616162.5Mean ± standard deviation (year)61.1 ± 1756.6 ± 15.662.4 ± 17.30.179ComorbidityDiabetes mellitus24 (26.1)6 (30)18 (25)1.29 (0.43--3.84)0.652Hypertension26 (28.3)4 (20)22 (30.6)0.57 (0.17--1.9)0.354End-stage renal disease5 (5.4)1 (5)4 (5.6)0.9 (0.09--8.49)0.999Malignancy40 (43.5)8 (40)32 (44.4)0.83 (0.3-2.28)0.723Liver cirrhosis8 (8.7)3 (15)5 (6.9)2.37 (0.51--10.89)0.365Chronic obstructive pulmonary disease9 (9.8)09 (12.5)0.197Type of infection acquisitionCommunity-acquired infection10 (10.9)2063 (87.5)0.197Healthcare-associated infection82 (89.1)09 (12.5)0.197Laboratory dataWhite blood cell count (cells/mm^3^)13,281 ± 874013,353 ± 668713,261 ± 92710.967Hemoglobin (g/dL)10.1 ± 2.19.8 ± 2.410.1 ± 2.10.585Platelet count (×1000 cells/mm^3^)228,570 ± 131,056216,550 ± 157,332231,900 ± 123,8460.69Serum creatinine (mg/dL)1.8 ± 1.71.6 ± 1.31.9 ± 1.80.584Empirical antimicrobial therapyβ-lactams41 (44.6)11 (55)30 (41.7)1.71 (0.63--4.64)0.289β-lactam/lactamase inhibitors20 (21.7)4 (20)16 (22.2)0.88 (0.26--2.99)0.999Ciprofloxacin10 (10.9)1 (5)9 (12.5)0.37 (0.04--3.1)0.685Levofloxacin24 (26.1)1 (5)23 (31.9)0.11 (0.01--0.89)0.015Carbapenems17 (18.5)4 (20)13 (18.1)1.14 (0.33--3.96)0.999Aminoglycosides9 (9.8)3 (15)6 (8.3)1.94 (0.44--8.57)0.402Tigecycline8 (8.7)2 (10)6 (8.3)1.22 (0.23--6.58)0.999Colistin6 (6.5)1 (5)5 (6.9)0.71 (0.08--6.41)0.999Inappropriate empirical antimicrobial therapy74 (80.4)20 (100)54 (75)0.01Shock42 (45.7)9 (45)33 (45.8)0.97 (0.36--2.62)0.999Admission to intensive care unit44 (47.8)9 (45)35 (48.6)0.87 (0.32--2.34)0.775Case fatality25 (27.2)6 (30)19 (26.4)1.2 (0.4--3.56)0.748[^1] should be replaced with the following: jcm-08-00546-t002_Table 2Table 2Demographic characteristics, clinical information, and outcome of patients with *E. meningoseptica* and *E. anophelis* infections.CharacteristicsAll (*n* = 92)Number of Episodes (%)OR (95% CI)*p-*Value*E. meningoseptica*\
(*n* = 20)*E. anophelis*\
(*n* = 72)SexMale64 (69.6)15 (75)49 (68.1)1.41 (0.46--4.35)0.55Female28 (30.4)5 (25)23 (31.9)0.71 (0.23--2.19)0.55AgeRange (year)3--8918--803--89Median (year)616162.5Mean ± standard deviation (year)61.1 ± 1756.6 ± 15.662.4 ± 17.30.179ComorbidityDiabetes mellitus24 (26.1)6 (30)18 (25)1.29 (0.43--3.84)0.652Hypertension26 (28.3)4 (20)22 (30.6)0.57 (0.17--1.9)0.354End-stage renal disease5 (5.4)1 (5)4 (5.6)0.9 (0.09--8.49)0.999Malignancy40 (43.5)8 (40)32 (44.4)0.83 (0.3-2.28)0.723Liver cirrhosis8 (8.7)3 (15)5 (6.9)2.37 (0.51--10.89)0.365Chronic obstructive pulmonary disease9 (9.8)09 (12.5)0.197Type of infection acquisitionCommunity-acquired infection9 (9.8)09 (12.5)0.197Healthcare-associated infection83 (90.2)2063 (87.5)0.197Laboratory dataWhite blood cell count (cells/mm^3^)13,281 ± 874013,353 ± 668713,261 ± 92710.967Hemoglobin (g/dL)10.1 ± 2.19.8 ± 2.410.1 ± 2.10.585Platelet count (×1000 cells/mm^3^)228,570 ± 131,056216,550 ± 157,332231,900 ± 123,8460.69Serum creatinine (mg/dL)1.8 ± 1.71.6 ± 1.31.9 ± 1.80.584Empirical antimicrobial therapyβ-lactams41 (44.6)11 (55)30 (41.7)1.71 (0.63--4.64)0.289β-lactam/lactamase inhibitors20 (21.7)4 (20)16 (22.2)0.88 (0.26--2.99)0.999Ciprofloxacin10 (10.9)1 (5)9 (12.5)0.37 (0.04--3.1)0.685Levofloxacin24 (26.1)1 (5)23 (31.9)0.11 (0.01--0.89)0.015Carbapenems17 (18.5)4 (20)13 (18.1)1.14 (0.33--3.96)0.999Aminoglycosides9 (9.8)3 (15)6 (8.3)1.94 (0.44--8.57)0.402Tigecycline8 (8.7)2 (10)6 (8.3)1.22 (0.23--6.58)0.999Colistin6 (6.5)1 (5)5 (6.9)0.71 (0.08--6.41)0.999Inappropriate empirical antimicrobial therapy74 (80.4)20 (100)54 (75)0.01Shock42 (45.7)9 (45)33 (45.8)0.97 (0.36--2.62)0.999Admission to intensive care unit44 (47.8)9 (45)35 (48.6)0.87 (0.32--2.34)0.775Case fatality25 (27.2)6 (30)19 (26.4)1.2 (0.4--3.56)0.748[^2]

The authors apologize for any inconvenience caused to the readers by these changes.

[^1]: Abbreviations: OR, odds ratio; CI, confidence interval.

[^2]: Abbreviations: OR, odds ratio; CI, confidence interval.
